Michal J. Besser
- Oncology top 0.5%
- CAR-T cell therapy research 60
- Cancer Immunotherapy and Biomarkers 19
- Immunology top 1%
- Immunotherapy and Immune Responses 37
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 11
- Biological Psychiatry top 5%
- Neurology top 5%
- Genetics top 5%
- Virus-based gene therapy research 17
-
- Cell Adhesion Molecules Research 10
-
- Viral Infectious Diseases and Gene Expression in Insects 7
Michal J. Besser
95 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 116
- Oncology 2.9k
- Immunology 1.9k
- Biological Psychiatry 117
- Neurology 197
- Genetics 612
Countries citing papers authored by Michal J. Besser
This map shows the geographic impact of Michal J. Besser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal J. Besser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal J. Besser more than expected).
Fields of papers citing papers by Michal J. Besser
This network shows the impact of papers produced by Michal J. Besser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal J. Besser. The network helps show where Michal J. Besser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michal J. Besser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 24 | |
| 6 | 2020 | 37 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 23 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2017 | 46 | |
| 13 | 2015 | 12 | |
| 14 | 2013 | 294 | |
| 15 | 2012 | 59 | |
| 16 | 2012 | 12 | |
| 17 | 2010 | 352 | |
| 18 | Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. | 2009 | 33 |
| 19 | 2006 | 49 | |
| 20 | 2003 | 150 |
About Michal J. Besser
Michal J. Besser is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 95 papers that have together received 4.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (60 papers), Immunotherapy and Immune Responses (37 papers), Cancer Immunotherapy and Biomarkers (19 papers), Virus-based gene therapy research (17 papers), Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers), Cell Adhesion Molecules Research (10 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (1.9k citations) and Biological Psychiatry (117 citations). Michal J. Besser has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Jacob Schachter, Gal Markel, Orit Itzhaki, Yonatan Ganor, Arnon Nagler, Rudolf Wank, Elad Jacoby, Avichai Shimoni, Avraham J. Treves and Adva Kubi. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.